Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the European Union (EU) to ...
Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...
Jeddah – United Pharmacies Group has announced the signing of its first strategic agreement for the manufacturing of ...
Trump's proposed tariffs on the EU would increase manufacturing costs for pharma companies and would stall medical innovation ...
According to NSE bulk deal data, Vanguard Emerging Markets Stock Index Fund A Series of VIEIF purchased 0.83 million shares ...
With its active pharmaceutical ingredient (API) facility “in a state of disrepair,” manufacturer Aspen Biopharma Labs’ operations have ground to a halt in the U.S., according to a recent FDA reprim | ...
Kotak Alternate Asset Managers has invested Rs 1,050 crore in Tirupati Medicare, facilitating the pharma company's growth and ...
The high court noted that SMA is a debilitating disease which has no cure, and the only approved drug, Risdiplam, marketed ...
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...
Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...
The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果